Psoriasis inducida por terapia biológica

Hernández, 2013, Lesiones cutáneas y terapia biológica con antagonistas del factor de necrosis tumoral, Reumatol Clin, 9, 53, 10.1016/j.reuma.2012.04.007 Oh, 2000, Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions, J Am Acad Dermatol, 42, 829, 10.1067/mjd.2000.105948 Puig, 2018, Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab Ixekizumab, and Others, 49, 10.1159/000479475 De Gannes, 2007, Psoriasis and Pustular Dermatitis Triggered by TNFα Inhibitors in Patients With Rheumatologic Conditions, Arch Dermatol., 143, 9, 10.1001/archderm.143.2.223 Sondermann, 2019, Dermatological complications of therapy with biologics in inflammatory autoinmmune diseases, J Disch Dermatol Ges., 17, 1029 Collamer, 2010, Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis, Semin Arthritis Rheum, 40, 233, 10.1016/j.semarthrit.2010.04.003 Asarch, 2009, Lichen planus-like eruptions: An emerging side effect of tumor necrosis factor-α antagonists, J Am Acad Dermatol, 61, 104, 10.1016/j.jaad.2008.09.032 Pugliese, 2015, Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study, Aliment Pharmacol Ther, 42, 880, 10.1111/apt.13352 Ciccarelli, 2016, Psoriasis Induced by Anti-Tumor Necrosis Factor Alpha Agents: A Comprehensive Review of the Literature, ACTA Dermatovenerol Croat, 24, 169 Guidelli, 2013, Induced psoriasis after rituximab therapy for rheumatoid arthritis: A case report and review of the literature, Rheumatol Int, 33, 2927, 10.1007/s00296-012-2581-3 Tanita, 2015, Psoriasiform drug eruption caused by abatacept: Inmunohistochemical investigation of STAT signaling, Case Rep Dermatol, 7, 166, 10.1159/000437415 Sparsa, 2014, Réactions cutanées paradoxales sous traitement par tocilizumab, Rev Médecine Interne, 35, 613, 10.1016/j.revmed.2014.01.007 Suh, 2018, Exacerbation of infliximab-induced paradoxical psoriasis after ustekinumab therapy, J Dermatol, 45, 332, 10.1111/1346-8138.13803 Puig, 2012, Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: Case report and review, Dermatol Basel Switz, 225, 14, 10.1159/000339864 Melo, 2018, Clinical management of Anti-TNF-alpha-induced psoriasis or psoriasiform lesions in inflammatory bowel disease patients: A systematic review, Int J Dermatol, 57, 1521, 10.1111/ijd.14072